UNSPSC 51391729: Midodrine

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H18N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6YE7PBM15H, chemically known as 2-amino-n-(2,5-dimethoxy-beta-hydroxyphenethylacetamide but generally known as midodrine, which bears US NIH Compound Identifier 4195. European Medicines Agency schedules Midodrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08954MIG.

UNSPSC 51391729 Midodrine is a Commodity code that nominally covers a specific pharmaceutical product, but recent state and local activity under this code shows a significant mismatch — the most recent opportunity available is Seminole County, Florida's IFB for naloxone and drug deactivation systems, which differs materially from midodrine's therapeutic scope. The source contains only one recent opportunity record, and that opportunity does not align with the code's pharmaceutical class designation. State and local buyers using this code appear limited, and the single recordable solicitation addresses emergency opioid-reversal supply rather than the orthostatic hypotension indication midodrine addresses.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems for annual procurement with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The bid cycle closed July 26, 2023, and the procurement included E-Verify compliance, drug-free workplace certification, and potential FEMA funding with associated federal compliance obligations. The source provides no evidence of related opportunities in other states or jurisdictions, and no pattern of repeat buying under this code emerges from the available data. Geographic activity is limited to Florida based on current records.